CheckMan Stock Market Overview

Spirit makes fuselages at the plant for Boeing's best-selling 737 Max plane, deliveries of which have slowed in the wake of a door panel blowout.

Archer Daniels (ADM) progresses well on its strategic growth pillars. The company is also actively managing productivity and innovation.

Growing momentum in AWS and expanding investments in generative AI are major tailwinds for Amazon.

Williams (WMB) decides to abandon the NESE pipeline project due to environmental concerns and regulatory challenges, and deems it as a poor investment.

GeoPark???s (GPRK) estimated production is set to increase to 5,500-6,500 boepd, contingent upon the closing date of the transaction.

DES MOINES, Iowa--(BUSINESS WIRE)--Principal, the No. 1 employee stock ownership plan (ESOP) service provider in the U.S., is acquiring the ESOP recordkeeping business from Ascensus.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of 2U, Inc. (“2U” or the “Company”) (NASDAQ: TWOU) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your 2U investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit y.

ST. JOHN'S, NL / ACCESSWIRE / May 16, 2024 / Sokoman Minerals Corp. (TSXV:SIC)(OTCQB:SICNF) ("Sokoman" or the "Company") is pleased to report that the 2024 exploration program at the 100%-owned Fleur de Lys gold project has commenced. An earlier-than-normal snow melt over the northern and central Baie Verte Peninsula has allowed prospecting to begin a full month earlier than usual.

The U.S. Food and Drug Administration has granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for treating adults with advanced small cell lung cancer that has worsened despite chemotherapy, Bloomberg News reported on Thursday.

Best known as a short seller and the founder of Citron Research, Andrew Left went short on GameStop Corporation GME in 2021 and again in May 2024.